ORMP Stock Analysis: Buy, Sell, or Hold?
ORMP - Oramed Pharmaceuticals Inc.
$3.99
0.04 (0.91%)
▲
5d:
-7.19%
30d:
+5.03%
90d:
+5.3%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When ORMP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ORMP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ORMP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ORMP is currently trading at $3.99, which is considered fair relative to its 30-day fair value range of $3.75 to $4.54.
Technical Outlook: Technically, ORMP is in a uptrend. Immediate support is located at $3.58, while resistance sits at $4.14.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.25 (+58.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ORMP is in a uptrend. Immediate support is located at $3.58, while resistance sits at $4.14.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.25 (+58.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.75 -
$4.54
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Trading 58.0% below Wall St target ($6.25)
- CAUTION: Recommendation downgraded due to -7.2% 5-day decline
Trading Range Analysis
30-Day Trading Range
$3.75 -
$4.54
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.58
Resistance Level
$4.14
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$6.25
(+58.0%)
Revenue Growth (YoY)
-100.0%
Earnings Growth (YoY)
40.9%
Share & Embed Analysis
Last updated: July 14, 2026 10:41 AM ET
Data refreshes hourly during market hours. Next update: 11:41 AM
Data refreshes hourly during market hours. Next update: 11:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ORMP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$441 | 60 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 62 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 67 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 61 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 59 HOLD |
